BUY PAIN MEDS - FREE RX, USA PHARMACY

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

<p>The transaction is conditioned upon approval by
Minrad's stockholders and other customary closing conditions. Advisors

UBS Investment Bank acted as exclusive financial advisor to Piramal
Healthcare. Total consideration for the merger
and acquisition of the notes, in cash plus the assumption of debt, will be
approximately $40 million. These devices enable
medical professionals to improve arthritis medicine the accuracy of interventional procedures and
reduce radiation exposure. Under the
terms of the agreement, Minrad will merge with a newly incorporated
wholly-owned subsidiary of Piramal. 91-9819334878

Shuchi / Priyanka
Hanmer nabumetone & Partners
Tel. Acted as exclusive financial advisor to
Minrad and Hodgson Russ LLP acted as legal advisor. </p>

<p>In light of the
significant uncertainties inherent in the forward-looking statements contained
in this , you should not place undue reliance on them. If the merger is completed, stockholders
of Minrad will receive $0.12 arthritis medicine per share in cash. Ma pain relief is somewhat of a hit-and-miss endeavor. Certain stockholders of Minrad, holding approximately 20% percent
of Minrad's outstanding com stock, have agreed to vote for approval of the
merger with Piramal. </p>

<p>These statements, including those
regarding the merger, the proxy statement and the combined company's growth,
continued success and prospects from the merger, have been included in
reliance on the "safe harbor" provisions of the ultracet Private Securities Litigation
Reform Act of 1995. These devices enable
medical professionals to improve the accuracy of interventional procedures and
reduce radiation exposure. For further information, About Minrad International, Inc. The transaction is conditioned upon approval by
Minrad's stockholders and other customary closing conditions. MUMBAI, India, / - / -- Piramal Healthcare
Limited [NSE. </p>

<p>The Group's turnover exceeded US$ 900
million in FY2008. PHL had consolidated revenues of US$ 580 million in
2007-08. That means there are more sore knees, hips and elbows seeking pain relief than ever before There are many products available and being marketed these drugstore days for joint pain relief. </p>

<p>PIRHEALTH) and the Bombay Stock Exchange
(Ticker. Supplements that contain CFA's can bring relief Piramal Healthcare Limited to Acquire Minrad International, Inc. In addition, Minrad has filed an bactroban ointment cost Abbreviated New Drug
Application (ANDA) for desflurane with the US Food and Drug Administration
(FDA). In connection with the merger
agreement, Piramal has also agreed <a href="http://www.moodle.medpaed.de/user/view.php?id=275&course=1&t=painreliefmedication">nsaid pain relievers</a> to acquire Minrad's 8% Senior Secured
Convertible Notes from the note holders. </p>

<p>Intends
to file a proxy statement and related materials concerning the transaction
with the U.S. Piramal Group
Vijay Sathye, President - M&A and Investor pain relievers Relations Tel. 91 (0) 22 3046 6474

Prasad Mhatre, Manager - Investor Relations Tel. </p>

<p>The supplement industry is working hard to keep people doing all the things they want to do. Upon closing of the merger, Piramal expects the transaction to be
accretive to its earnings for the fiscal year ending. The words
"expect," "plan," "will" and similar expressions are generally intended to
identify forward-looking statements. Waller Lansden Dortch & Roma, LLP, Ashurst LLP and Mendie Tymothy LLP
acted as legal advisors tramadol to Piramal Healthcare in connection with the
transaction. </p>

<p>Additional
information can be found at the company's website,. When available,
Minrad International will mail the proxy statement and related materials to
its stockholders. The real-time image guidance products facilitate minimally
invasive surgery especially for pain management and have broad applications in
orthopedics, neurosurgery, and interventional radiology. Study results show that not only do people <a href="http://www.iesnules.com/moodle/user/view.php?id=225&course=1&t=painreliefforarthritis">steroids pain relief</a> feel better quicker, but they also reach higher levels of relief that improve with continued use. Concurrently, with the signing of the merger agreement, Piramal provided
Minrad with a senior secured loan of $12 million to provide Minrad with
capital for operations during the period preceding the closing of the merger. Upon completion of the prescription medicines merger, the combined company will have a marketing
and sales network across 108 countries with 178 distributors, capable of
supplying anesthetic products to supply chain vendors and end users, including
hospitals, pain management clinics, veterinary hospitals, university research
centers, and medical industrial users. </p>

<p>Piramal Group
Ganesh Somwanshi
Corporate Communications
Piramal Group
Contact. There are more and more people discovering that joint pain relief does not have to be a permanent fixture in their everyday lives. Cetylated fatty acids have been shown natural pain relief to dramatically improve the range of movement in previously inflamed joints. 500302], one of India's largest pharmaceutical
and healthcare companies, and Minrad International, Inc. Piramal is a leading producer of halothane and isoflurane, while Minrad's
product portfolio of inhalation anaesthetics consists of isoflurane, enflurane
and sevoflurane. Total consideration for the merger
and acquisition of the generic crestor notes, in cash plus the drugstore assumption of debt, will be
approximately $40 million. Minrad
undertakes no obligation to update any forward-looking statements or to make
any other forward-looking statements, whether as a result of new information,
future events or otherwise. Piramal Healthcare <a href="http://online.eminus.us/user/view.php?id=86&course=1&t=backpainrelief">get prescription drugs</a> Limited to Acquire Minrad International, Inc. </p>

<p>Is an interventional pain management company
with real-time image guidance, anesthesia and analgesia, conscious sedation
product lines. The Group's turnover pain killers exceeded US$ 900
million in FY2008. Minrad International and its directors and executive officers may be
deemed to be participants in the solicitation of proxies from Minrad
International stockholders in connection with the proposed merger. These statements involve risks, uncertainties and other
factors that may cause actual results to differ from the expectations
expressed in the statements. Advisors UBS Investment Bank acted as exclusive financial advisor to Piramal
Healthcare. Certain
information regarding the participants and their interests in the solicitation
is set forth in the proxy statement for Minrad International's online pharmacies 2008 annual
meeting of stockholders filed with the SEC on , and a Form
10-KSB/A filed by Minrad International with the SEC on , both of
which are available free of charge from the SEC and Minrad International at
their web sites as indicated above. Additional
information can be found at the company's website,. The real-time image guidance products facilitate minimally
invasive pain treatment surgery especially for pain management and have broad applications buy imitrex online in
orthopedics, <a href="http://isaac.ssl.berkeley.edu/cplan/view_profile.php?userid=2006&t=naturalpainrelief">gout knee pain relief</a> neurosurgery, and interventional radiology. </p>

<p>We hope to
complete it as soon as possible." The Boards of Directors of Piramal and Minrad have approved the
transaction. Our Board believes the transaction is in the best interests of
all our stakeholders, and also allows our employees to continue growing the
Minrad business as part of a global leader in anesthetic products. About the Piramal Group

Spanning a broad spectrum of industries and formats, the Piramal Group is
committed to achieving excellence online pharmacies and leadership by adhering to ethically
sound, innovative and value-driven practices in its diverse, yet focused,
business ventures and initiatives. Is an interventional pain tretinoin gel management company
with real-time image guidance, anesthesia and analgesia, conscious sedation
product lines. "The proposed transaction with
Piramal is the result of an extended process undertaken by our Board of
Directors and financial advisors to address the company's capital
requirements. The company is developing a drug/drug delivery system for
conscious sedation, which, similar to nitrous oxide in dental surgery,
provides a patient with pain relief without loss of consciousness. </p>

<p>Executive Vice President and CFO
(716) 855-1068

Notes to Editors. THESE DOCUMENTS
WILL pain pills CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER AND STOCKHOLDERS
ARE URGED TO Tabor THEM CAREFULLY WHEN THEY BECOME AVAILABLE. PHL is listed in India on the
National Stock Exchange (Ticker. Information regarding the interests of
these persons in the solicitation will be more specifically set forth in the
proxy statement concerning the proposed merger that will be filed by Minrad
International with the SEC and which will be available free of charge from the
Minrad International and the SEC at their websites, as indicated above. </p>

<p>The Company is also
one of the largest custom manufacturing companies with a global footprint of
assets across North America, Europe and Asia. PHL is listed in India on the
National Stock Exchange (Ticker. Many of these factors are beyond the ability of
Minrad to control or predict. These are naturally occurring acids that have been esterified. BUF), a
provider of chantix starter pack price generic inhalation anesthetics, jointly pain relievers announced that they have
signed a definitive merger agreement for Piramal to acquire Minrad. MUMBAI, India, / - / -- Piramal Healthcare
Limited [NSE. </p>

<p>Certain
information regarding the participants and their interests in the solicitation
is set forth in the proxy statement for Minrad International's 2008 annual
meeting of stockholders filed with the SEC on , and a Form
10-KSB/A filed by Minrad International with the SEC on , both of
which are available free of charge from the SEC and Minrad International prescription drugs at
their web sites as indicated above. The fact is, the population here in the United States is one that is aging. Our
dedication to building the Critical Care business is a reflection of our
commitment to knowledge and innovation, dynamic action and care that empowers
-- consistent with our Group's values."

Chalmers DiGiacinto, President of Minrad said. Certain stockholders of Minrad, holding approximately 20% percent
of online pharmacy Minrad's outstanding com stock, have agreed to vote for approval of the
merger with Piramal. </p>

<p>Our
dedication to building the Critical Care business is a reflection of our
commitment to knowledge and innovation, dynamic action and care that empowers
-- consistent with our Group's values." Filmore DiGiacinto, President of Minrad said. The Company is currently ranked 4th in the Indian market with a
diverse product portfolio spanning nine therapeutic areas. The company butalbital apap caffeine is developing a drug/drug delivery system for
conscious sedation, which, similar to nitrous oxide in dental surgery,
provides a patient with pain relief without loss of consciousness. About the Piramal Group Spanning a broad spectrum of industries and formats, the Piramal Group is
committed to achieving excellence and leadership by adhering to ethically
sound, innovative and value-driven practices in its diverse, yet focused,
business ventures and initiatives. "The proposed transaction with
Piramal prescription drugs is the result of an extended process undertaken by our Board of
Directors and financial advisors to address the company's capital
requirements. In connection with the merger
agreement, Piramal has also agreed to acquire Minrad's 8% Senior Secured
Convertible Notes from the note holders. </p>

<p>The strategic combination will give Piramal access to key intellectual
property gemfibrozil cost for the manufacture of inhalation anesthetics, including
process-based intellectual property for both sevoflurane and desflurane, and
will provide Piramal an immediate entry into the US market for sevoflurane,
the largest selling inhalation anesthetic in the US. These studies have also revealed that relief can be achieved without side effects, making them butalbital apap caffeine a very attractive option. It is not
subject to any financing contingency and is expected to close in the first
quarter of 2009. </p>

<p>Under the
terms of the agreement, Minrad will merge with a newly incorporated
wholly-owned subsidiary of Piramal. Information regarding the interests of
these persons in the solicitation canadian pharmacy online viagra will be more specifically set forth in the
proxy statement concerning the proposed merger that will be filed by Minrad
International with the SEC and which will be available free of charge from the
Minrad International and the SEC at their websites, as indicated above. THESE DOCUMENTS
WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER AND STOCKHOLDERS
ARE URGED TO Phillip THEM CAREFULLY WHEN THEY BECOME AVAILABLE. BUF), a
provider of generic inhalation anesthetics, jointly announced that they have
signed a definitive merger agreement for Piramal to acquire Minrad. Edee Piramal, Chairman, Piramal Group
said, "The offer to Minrad is consistent with our commitment to build a
serious global presence in Critical Care. cost laser hair removal treatment Upon completion of the merger, the combined company will have a marketing
and sales network across 108 countries with 178 distributors, capable of
supplying anesthetic products to supply chain vendors and end users, including
hospitals, pain management clinics, veterinary hospitals, university research
centers, and medical industrial users. </p>

<p>When filed with the SEC, the proxy statement and related
materials will be available for free (along with any other document and
reports filed by Minrad International with the SEC) at the SEC's website, , and at the Minrad International website,. Afton Piramal, Chairman, Piramal Group
said, "The offer to Minrad is consistent with our commitment to build a
serious global presence in Critical Care. Important Information about the Merger In connection with the proposed merger, Minrad International, Inc. These factors include, without limitation. Concurrently, with the signing of the merger agreement, Piramal provided
Minrad with a senior secured loan of $12 million to provide Minrad with
capital for operations during the period preceding the closing of the merger. </p>

<p>Intends
to file a proxy statement and related materials concerning the transaction
with the U.S. These factors include, without limitation. Many people have discovered that between the relief from inflammation and pain, as well as the increase in movement, they xenical price are able to accomplish tasks that had been difficult or impossible to achieve before they started using CFA's. The strategic combination will give Piramal access to key intellectual
property for the manufacture of inhalation anesthetics, including
process-based intellectual property for both sevoflurane and desflurane, and
will provide Piramal an immediate entry into the US market for sevoflurane,
the largest selling inhalation anesthetic in the US. </p>

<p>Waller Lansden Dortch & Agosto, LLP, Ashurst LLP and Saunderson Chan LLP
acted as legal advisors to Piramal Healthcare in connection with the
transaction. The reason CFA's are so exciting is because there have been several studies that have shown them to reduce joint inflammation. Upon closing of the merger, Piramal expects the transaction to be
accretive to cheap tramadol online its earnings for the fiscal year ending. Many of these are obtainable as supplements and have brought immense relief to sufferers everywhere. Commenting on the acquisition, Mr. </p>

<p>This contains forward-looking statements based on Minrad
management's current expectations and projections about future events and
trends that management believes may affect Minrad's financial condition,
results of operations, business strategy and financial needs. (i)
the occurrence of any event, change or other circumstances that could give
rise to the termination of the merger agreement; (ii) the outcome of any legal
proceedings that may be instituted against Minrad and others following
announcement of the merger agreement; (iii) the inability to complete the
merger due to the failure to obtain stockholder approval or the failure to
satisfy other conditions to completion of the merger; (iv) risks that the
proposed transaction disrupts current plans and operations and the potential
difficulties in employee retention as a result of the merger; (v) the ability
to recognize the benefits of the merger; (vi) the amount of the costs, fees,
expenses and charges related to the merger and the actual terms of certain
financings that will be obtained for the merger; and (vii) other risks and
uncertainties detailed from time to time in Minrad's filings with the
Securities and Exchange Commission; including those risks described under the
heading "Risk Factors" of Minrad International's Form 10-KSB/A, filed with the
Securities and Exchange Commission on. In light of the
significant uncertainties inherent in the forward-looking statements contained
in this , you should not place undue reliance on them. Many of these factors are beyond the ability of
Minrad to control telmisartan and hydrochlorothiazide or predict. It is not
subject to any financing contingency and is expected to close in the first
quarter of 2009. We respect the leading work that
Minrad scientists and workforce have built over the past many years. SOURCE Minrad International, Inc. </p>

<p>Piramal is a leading producer of halothane and isoflurane, while Minrad's
product portfolio of inhalation anaesthetics consists of isoflurane, enflurane
and sevoflurane. Cetylated fatty acids have been a terrific addition to the options currently available over the counter, specifically for joint pain. 500302], one of India's largest pharmaceutical
and healthcare companies, and Minrad International, Inc. </p>

<p>PHL had consolidated revenues of US$ 580 million in
2007-08. 91 (0) 22 3046 6412,
Sagar Gokani, Manager - Investor Relations Tel. If the merger is completed, stockholders
of Minrad will receive $0.12 per share in cash. Joint Pain Relief and CFAs Painful joints seem to be the bane of those who have more years under their belt. Securities and Exchange Commission, or SEC. Acted as exclusive financial advisor to
Minrad and Hodgson Nathanil LLP acted as legal advisor. People are living longer and more active lives. </p>

<p>91-9987059571 / 91-98336 99707



Minrad International, Inc
Maddie R. Minrad International and its directors and executive officers may be
deemed to be participants in the solicitation of proxies from Minrad
International stockholders in connection with the proposed merger. We respect the leading work that
Minrad scientists and workforce have built over the past many years. These statements involve risks, uncertainties and other
factors that may cause actual results to differ from the expectations
expressed in the statements. (i)
the occurrence of any event, change or other circumstances that could give
rise to the termination of the merger agreement; (ii) the outcome of any legal
proceedings that may be instituted against Minrad and others following
announcement of the merger agreement; (iii) the inability to complete the
merger due to the failure to obtain stockholder approval or the failure to
satisfy other conditions to

---

---